Website News Blog

Tag: ZYUS

ZYUS Life Sciences Receives No Objection Letter from Health Canada for Proof-of-Concept Trial – Journal Today Internet

SASKATOON, Saskatchewan, July 30, 2024–(BUSINESS WIRE)–ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based chronicle sciences interact focused on the utilization and utilization of infant cannabinoid-based professional verify candidates for discomfit management, is entertained to forebode that its totally owned subsidiary, ZYUS Life Sciences Inc., has customary a No Objection Letter (“NOL”) from Health …

ZYUS Life Sciences Receives No Objection Letter from Health Canada for Proof-of-Concept Trial – Journal Today InternetRead More